Literature DB >> 24286008

Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice.

Merina Varghese1, Wei Zhao, Jun Wang, Alice Cheng, Xianjuan Qian, Amna Chaudhry, Lap Ho, Giulio Maria Pasinetti.   

Abstract

Alzheimer's disease (AD) is an age-related dementia, with the pathological hallmarks of neuritic plaques and neurofibrillary tangles, brain atrophy and loss of synaptic terminals. Dysfunctional mitochondrial bioenergetics is implicated as a contributing factor to the cognitive decline observed in AD. We hypothesized that, in the presence of the AD neurotoxic peptide beta-amyloid, mitochondrial respiration is impaired early in synaptic terminals, which are vital to cognitive performance, preferentially in cognitive centers of the brain. We compared oxygen consumption in synaptosomal and perikaryal mitochondria prepared from the cerebral cortex and cerebellum of wild type (WT) and AD transgenic Tg2576 mice. Compared to WT mice, Tg2576 mice showed decreased mitochondrial respiration in the cerebral cortex specifically in synaptosomal fraction, while the perikaryal mitochondria were unaffected. Neither mitochondrial fraction was affected in the cerebellum of Tg2576 mice as compared to WT. The occurrence of a bioenergetic defect in synaptic terminals of mice overexpressing mutant beta-amyloid, in particular in an area of the brain important to cognition, points to an early role of mitochondrial defects in the onset of cognitive deficits in AD.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; Dementia; Energy Metabolism; Memory; Mitochondria; Oxidative phosphorylation; Oxygen Consumption; Tg2576

Year:  2011        PMID: 24286008      PMCID: PMC3839672          DOI: 10.2478/s13380-011-0011-8

Source DB:  PubMed          Journal:  Transl Neurosci        ISSN: 2081-6936            Impact factor:   1.757


  23 in total

1.  Brain cytochrome oxidase in Alzheimer's disease.

Authors:  S J Kish; C Bergeron; A Rajput; S Dozic; F Mastrogiacomo; L J Chang; J M Wilson; L M DiStefano; J N Nobrega
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

2.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

3.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

Authors:  I Maurer; S Zierz; H J Möller
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD.

Authors:  D A Cottrell; E L Blakely; M A Johnson; P G Ince; D M Turnbull
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

5.  Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.

Authors:  R F Butterworth; A M Besnard
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

6.  Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.

Authors:  Natasa Dragicevic; Malgorzata Mamcarz; Yuyan Zhu; Robert Buzzeo; Jun Tan; Gary W Arendash; Patrick C Bradshaw
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.

Authors:  Heng Du; Lan Guo; Shiqiang Yan; Alexander A Sosunov; Guy M McKhann; Shirley ShiDu Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

8.  Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.

Authors:  Jun Wang; Lap Ho; Wei Zhao; Kenjiro Ono; Clark Rosensweig; Linghong Chen; Nelson Humala; David B Teplow; Giulio M Pasinetti
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

9.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

Authors:  J V Haxby; C L Grady; R Duara; N Schlageter; G Berg; S I Rapoport
Journal:  Arch Neurol       Date:  1986-09
View more
  7 in total

Review 1.  Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Rebecca Parodi-Rullán; Je Yeong Sone; Silvia Fossati
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  No consistent bioenergetic defects in presynaptic nerve terminals isolated from mouse models of Alzheimer's disease.

Authors:  Sung W Choi; Akos A Gerencser; Ryan Ng; James M Flynn; Simon Melov; Steven R Danielson; Bradford W Gibson; David G Nicholls; Dale E Bredesen; Martin D Brand
Journal:  J Neurosci       Date:  2012-11-21       Impact factor: 6.167

3.  A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease.

Authors:  Paul Denver; Heather D'Adamo; Shuxin Hu; Xiaohong Zuo; Cansheng Zhu; Chihiro Okuma; Peter Kim; Daniel Castro; Mychica R Jones; Carmen Leal; Marisa Mekkittikul; Elham Ghadishah; Bruce Teter; Harry V Vinters; Gregory Michael Cole; Sally A Frautschy
Journal:  Front Physiol       Date:  2019-10-24       Impact factor: 4.566

Review 4.  Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.

Authors:  Elisa Canepa; Silvia Fossati
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

Review 5.  Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia.

Authors:  Tuo Yang; Feng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

6.  The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type.

Authors:  Katie Richardson; Scott P Allen; Heather Mortiboys; Andrew J Grierson; Stephen B Wharton; Paul G Ince; Pamela J Shaw; Paul R Heath
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

7.  Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.

Authors:  G O'Neal-Moffitt; V Delic; P C Bradshaw; J Olcese
Journal:  Mol Neurodegener       Date:  2015-07-11       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.